Stivarga

Stivarga

Basic Prescribing Info
Contents
Regorafenib (as monohydrate)
MIMS Class
Targeted Cancer Therapy
ATC Classification
L01EX05 - regorafenib ; Belongs to the class of other protein kinase inhibitors. Used in the treatment of cancer.
Exclusive offer for doctors
Register for a MIMS account and receive free medical publications worth $139 a year.
Already a member? Sign in
Exclusive offer for doctors
Register for a MIMS account and receive free medical publications worth $139 a year.
Already a member? Sign in